AKASA vs Lyric (2026)
The provider's coding engine against the payer's editing engine, which between them decide what a claim ends up worth. Lyric edits on the way in, with thirty years of rules and policy content underneath and the strongest third party validation in the payer cluster. AKASA prepares the claim on the way out, running one engine across coding, documentation integrity and claim work for the health system. Each side's improvement becomes the other's problem, and both bill for the escalation. For a buyer the decision is trivially determined by which side you are on. For anyone reading the index as a whole, this pair and the others like it show how much of American healthcare AI spending is two parties automating a dispute rather than either of them removing it.
- One engine spans provider side coding, clinical documentation integrity and the claim work around them, so a health system standardizes the function on one vendor.
- The longer commercial track record in generative revenue cycle work matters for a function touching every encounter.
- For an enterprise program, breadth across the function reduces the handoffs where errors accumulate.
- The pre payment editing engine carries more than three decades of rules and policy content, which is the asset the machine learning sits on rather than a model trained from scratch.
- The strongest third party validation in the payer side cluster, including a named recognition for pre payment accuracy.
- Integration targets payer core systems, the correct architecture for that buyer.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. AKASA and Lyric are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
Side by Side
Select any grade to read the note behind it.
Product updates
The latest logged changes from each vendor, newest first, each linked to its source.
AKASA
-
Product / capability
AKASA launched an autonomous platform for inpatient medical coding and clinical documentation integrity, building on its AI prebill review products.
Source
Lyric
-
Product / capability
Lyric made expert review generally available in Lyric42, letting health plans hold selected claims during adjudication for a targeted review by an expert.
Source
Each vendor in one paragraph
Written to be quoted whole. Each paragraph opens the AI Health Index profile of the vendor: what the product is, who buys it and what it does.
AKASA, formerly Alpha Health, sells generative AI for the provider side of the revenue cycle to hospitals and health systems. Its listed solutions are the Prebill Optimization Suite, which combines Coding Optimizer (missed coding opportunities, quality and compliance risks) and CDI Optimizer (documentation gaps for clinical documentation integrity teams); AI Advisor, a research assistant for revenue cycle staff; Auth Status, which checks pending prior authorization requests on payer portals and records the results; and Claim Status, which does the same for outstanding claims.
Source: AI Health Index, August 2026
Payment accuracy for health plans, founded 1989, whose pre payment editing is the former ClaimsXten with 35+ years of rules and policy content behind it. Solutions span primary and secondary editing and content programs (Edit), coding review, coordination of benefits and data mining (Review), Policy Studio, Virtuoso, Replay and C3 (Enhance), and clinical and reimbursement policies (Guide).
Source: AI Health Index, August 2026
Questions buyers ask
How are AKASA and Lyric priced and sold?
AKASA sells to hospitals and health systems by solution, each with its own demo request. The platform page describes a dedicated account manager, production reporting, and the option of AKASA's own revenue cycle experts taking over workflows rather than staff using the tools, a service component that will shape the cost.
Lyric sells enterprise agreements to health plans across editing, review, enhancement and policy content, orchestrated through Lyric42. Nothing states whether it prices on license or contingency against savings; the distinction changes the vendor's incentive from getting payment right first time toward finding more overpayments. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified August 4, 2026. No vendor pays for placement.
How do AKASA and Lyric handle patient data?
In AKASA's case, the data is complete clinical and financial documentation for whole health systems. Safety engineering, meaning guardrails, hallucination mitigation and how a safety event is handled, is not described.
Lyric's security and trust page describes encryption, access controls, zero trust practices and continuous monitoring over the PHI it holds, and HITRUST certifications including an AI security certification. Its home page reports 10 billion claim lines a year and says nine of the top ten US health plans verify claims with it, so the data concentration is very large, and review work reaches medical records. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified August 4, 2026. No vendor pays for placement.
Which settings and specialties do AKASA and Lyric cover?
AKASA sells to hospitals and health systems, states a client base of 500 hospitals across all 50 states, and covers coding and documentation integrity before billing, prior authorization status, claim status and a research assistant for revenue cycle staff.
Lyric says nine of the top ten US health plans verify claims with it, and it holds 2025 Best in KLAS for pre payment accuracy and integrity. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified August 4, 2026. No vendor pays for placement.
What evidence is published for AKASA and Lyric?
For AKASA, the 2024 Authorization Advisor launch claimed up to 50 percent less time on prior authorization and models 38 percent more accurate than GPT-4 at selecting documents, with no test set or method. Cleveland Clinic is deploying the coding and documentation tools, with no results published.
With Lyric, the home page reports 35+ years of operation, nine of the top ten US health plans as customers, 10 billion claim lines a year and $20 billion in annual savings realized by clients, which are scale and vendor totals without method. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified August 4, 2026. No vendor pays for placement.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the RCM & Prior Auth AI page.
Each vendor's output becomes the other's input, which is the structural fact underneath this comparison: better provider documentation reduces payer edits, and better payer edits force better provider documentation, and both sides bill for the improvement. Neither publishes an independent evaluation of its returns.
Payment integrity sold on contingency rewards finding more rather than finding correctly, and provider side coding assistance carries the mirror incentive, so ask each for a two way number rather than a savings figure. Neither publishes a bias evaluation or pricing.